General Information of the Compound
Compound ID
CP0071636
Compound Name
956104-40-8
    Show/Hide
Synonyms
ARN-509
Arn-509 (AR inhibitor)
    Show/Hide
Structure
Formula
C21H15F4N5O2S
Molecular Weight
477.443
Canonical SMILES
CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C11CCC1)c1cnc(C#N)c(c1)C(F)(F)F
    Show/Hide
InChI
InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)
    Show/Hide
InChIKey
HJBWBFZLDZWPHF-UHFFFAOYSA-N
CAS
956104-40-8
Physicochemical Property
logP
3.53158
Rotatable Bonds
3
Heavy Atom Count
33
Polar Areas
89.33
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24872560
SID: 50127665
ChEMBL ID
CHEMBL3183409
DrugBank ID
DB11901
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
2
IC50 = 160 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 200 nM
2 Ki = 34.7 nM
3 Ki = 93 nM
4 Ki = 1452 nM
Clinical Information about the Compound
Drug 1 ( ARN-509 )
Drug Name ARN-509
Company Johnson & Johnson
Indication
Acute myeloid leukaemia
Approved
Prostate cancer
Phase 3
Target(s)
Androgen receptor (AR)
Inhibitor